Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
1 hedge funds and large institutions have $32 invested in Axcella Health Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 14 closing their positions.
93% less funds holding
Funds holding: 15 → 1 (-14)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $17.1M → $32 (-$17.1M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 14
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
-$12.2M |
| 2 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
-$2.59M |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.05M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$694K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$334K |
AXLA Hedge Fund Activity: Q4 2023 in Review
1 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q4 2023, worth a combined $32 — down 100% from $17.1M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of AXLA and 0 opened new positions — a net loss of 14 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Flagship Pioneering, exiting entirely with an estimated $12.2M sold.
- 1 institutional investor held Axcella Health Inc. Common Stock (AXLA) as of Q4 2023, down from 15 in Q3 2023.
- Funds reported $32 of Axcella Health Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Axcella Health Inc. Common Stock positions in Q4 2023 and 14 closed out, a net change of -14 holders.
- The largest Axcella Health Inc. Common Stock seller in Q4 2023 was Flagship Pioneering, an estimated $12.2M sold.
Based on aggregated 13F filings for Q4 2023.